z-logo
open-access-imgOpen Access
Safety of Tofacitinib in the COVID-19 Pandemic—Enough Is Not Enough
Author(s) -
Philipp A. Reuken,
Niels Teich,
Andreas Stallmach
Publication year - 2021
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izab051
Subject(s) - tofacitinib , covid-19 , pandemic , medicine , virology , immunology , rheumatoid arthritis , outbreak , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom